UTMD

In the first quarter of 2026, consolidated sales were $987,000 lower than in Q1 2025, primarily due to the absence of sales to its previous largest medical device distributor in China and its former OEM customer, PendoTECH. On February 4, 2026, Utah Medical Products, Inc. announced a quarterly dividend. As of May 4, 2026, UTMD's stock price was $64.81, with a 52-week range of $51.80 to $71.81. On May 1, 2026, stockholders elected directors and ratified the selection of Haynie & Co. as the independent public accounting firm for 2026. Following its earnings release 40 days prior to May 10, 2026, UTMD stock drifted 3.5% higher, trading in a range between $60.05 and $68.71. In the past year, UTMD's profit was reduced by $1.4 million due to unusual items.